Xeris Biopharma Holdings Inc. buy Barclays PLC
Start price
08.12.25
/
50%
€5.78
Target price
08.12.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.12.26. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Xeris Biopharma Holdings Inc. | - |
| iShares Core DAX® | 1.917% |
| iShares Nasdaq 100 | 0.911% |
| iShares Nikkei 225® | 0.833% |
| iShares S&P 500 | 0.242% |
Comments by Barclays_PLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for XERS provided by MarketBeat